Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®

Study Identifier
MAF/AGN/OPH/RET/016
CT.gov Identifier
NCT02181530
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Macular Edema
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    N/A
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Macular oedema in at least one eye due to branch retinal vein occlusion (BRVO) or central vein occlusion (CRVO) * Received at least one injection of OZURDEX® in the study eye
    Exclusion Criteria:
    * None

    Protocol Summary

    This study will use retrospective data to evaluate the safety and efficacy of OZURDEX® (dexamethasone intravitreal implant 0.7 mg) in the treatment of macular oedema due to retinal vein occlusion (RVO) in clinical practice. No intervention will be administered as part of this study.

    Study Locations

    Location
    Status
    Location
    Warsaw, Poland
    Status
    Not applicable